Clinical Trial Update: A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years [Phase 2]

View source ↗

Summary

This completed Phase 2 study evaluated an investigational regimen that includes marketed HIV drugs in pediatric participants aged 2 to 18 years with HIV infecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infection | Phase 2 | Status: COMPLETED | Results posted: 2010-02-23